Zeta Health Care Converts ₹119.52 Cr Debt into Equity in Hacienda Health Mart, Fortifies Subsidiary
Zeta Health Care Limited has taken a major step to strengthen the financial position of its wholly owned subsidiary, Hacienda Health Mart Limited, by converting outstanding loans into equity. The company announced on July 17, 2026, that it has acquired an additional 2,35,512 equity shares of Hacienda through a preferential allotment valued at approximately ₹119.52 crore.
The transaction forms part of Zeta Health Care’s broader strategy to improve the group’s financial structure while supporting the continued expansion of its rapidly growing generic pharmacy business.
Loan Conversion to Strengthen Balance Sheet
Unlike a conventional cash investment, the transaction was executed through the conversion of unsecured loans, along with accrued interest, previously extended by Zeta Health Care to Hacienda Health Mart.
By converting debt into equity, the company aims to reduce consolidated borrowings, strengthen its balance sheet, and enhance the group’s overall net worth. The move also reflects the parent company’s long-term commitment to supporting the subsidiary’s growth and improving its financial flexibility.
Transaction Highlights
- Equity Shares Acquired: 2,35,512
- Investment Value: ₹119.52 crore
- Mode of Consideration: Conversion of outstanding unsecured loans and accrued interest into equity
- Objective: Reduce consolidated debt, improve net worth, and strengthen Hacienda Health Mart’s capital base
Hacienda Health Mart Continues Rapid Expansion
Established on January 1, 2020, Hacienda Health Mart has emerged as one of India’s fast-growing Company Owned, Company Operated (COCO) generic pharmacy chains.
As of June 30, 2026, the company operated 1,855 pharmacy stores across the country. Its outlets offer more than 2,000 stock-keeping units (SKUs), including:
- Generic and branded medicines
- Ayurvedic products
- Nutraceuticals
- Cosmetics
- Over-the-counter (OTC) healthcare products
The rapid expansion of its retail footprint highlights the growing demand for affordable healthcare and generic medicines across India.
Revenue Growth Reflects Strong Business Momentum
Hacienda Health Mart has recorded remarkable revenue growth over the past three financial years.
- FY26: ₹267.71 crore
- FY25: ₹109.93 crore
- FY24: ₹44.77 crore
Although the subsidiary reported a net loss of ₹103.87 crore during FY26, its net worth stood at ₹111.41 crore, indicating continued investment in business expansion and store network development.
Strategic Move Signals Long-Term Confidence
The equity conversion demonstrates Zeta Health Care’s confidence in Hacienda Health Mart’s long-term growth potential. Strengthening the subsidiary’s capital structure is expected to provide greater financial stability, support future expansion, and improve operational efficiency as the pharmacy chain scales its business.
With India’s generic pharmaceutical retail market witnessing sustained growth, Hacienda Health Mart is well positioned to capitalize on increasing consumer demand for affordable healthcare solutions. The latest capital infusion further reinforces Zeta Health Care’s strategy of building a stronger, financially resilient healthcare business capable of delivering long-term value to shareholders